A polygenic score for type 2 diabetes risk is associated with both the acute and sustained response to sulfonylureas

21Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is a limited understanding of how genetic loci associated with glycemic traits and type 2 diabetes (T2D) influence the response to antidiabetic medications. Polygenic scores provide increasing power to detect patterns of disease pre-disposition that might benefit from a targeted pharmacologic intervention. In the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH), we constructed weighted polygenic scores using known genome-wide significant associations for T2D, fasting glucose, and fasting insulin, comprising 65, 43, and 13 single nucleotide polymorphisms, respectively. Multiple linear regression tested for associations between scores and glycemic traits as well as pharmacodynamic end points, adjusting for age, sex, race, and BMI. A higher T2D score was nominally associated with a shorter time to insulin peak, greater glucose area over the curve, shorter time to glucose trough, and steeper slope to glucose trough after glipizide. In replication, a higher T2D score was associated with a greater 1-year hemoglobin A1c reduction to sulfonylureas in the Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS) study (P = 0.02). Our findings suggest that individuals with a higher genetic burden for T2D experience a greater acute and sustained response to sulfonylureas.

References Powered by Scopus

Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

27963Citations
N/AReaders
Get full text

Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the european association for the study of diabetes (EASD)

2074Citations
N/AReaders
Get full text

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

1808Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association

198Citations
N/AReaders
Get full text

Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations

57Citations
N/AReaders
Get full text

A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics

32Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, J. H., Szczerbinski, L., Dawed, A. Y., Kaur, V., Todd, J. N., Pearson, E. R., & Florez, J. C. (2021). A polygenic score for type 2 diabetes risk is associated with both the acute and sustained response to sulfonylureas. Diabetes, 70(1), 293–300. https://doi.org/10.2337/db20-0530

Readers over time

‘20‘21‘22‘23‘2407142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

82%

Professor / Associate Prof. 2

9%

Researcher 2

9%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 9

45%

Medicine and Dentistry 8

40%

Pharmacology, Toxicology and Pharmaceut... 2

10%

Neuroscience 1

5%

Save time finding and organizing research with Mendeley

Sign up for free
0